Review



mouse monoclonal anti trf2  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Santa Cruz Biotechnology mouse monoclonal anti trf2
    a The diagram shows the workflow on a timeline: on the day after cell seeding, cells were treated with RHPS4 (0.2 and/or 0.5 μM). At 48 h after treatment, cells were again treated with RHPS4 (0.2 and/or 0.5 μM) or harvested and counted. At 72 h after the first treatment, the cell viability was checked, and finally at 96 h after the first treatment, the cells were harvested and processed. b Representative images showing U251MG cells stained by immunofluorescence using anti-BLM (red signals), and anti-TRF1 <t>or</t> <t>anti-TRF2</t> (green signals) antibodies. Merged images allow visualization of colocalizing dots (yellow signals). Yellow arrows indicate BLM and TRF1-TRF2 colocalizations. c Quantification of the colocalizations between BLM and TRF1 or TRF2 proteins in U251MG cell line upon RHPS4 treatment (0.2 and 0.5 μM). d , e Sensitivity of U251MG and BLM −/− cell lines to RHPS4 concentrations ranging from 0.01 to 2 μM (0.01; 0.125; 0.25; 0.5; 1; 2 μM), evaluated 96 h after the first treatment. Mitomycin C (MMC) was used as a positive control at concentrations of 0.1; 0.5; 1; 2; 5 μg/ml. The Sulforhodamine B (SRB) cytotoxicity assay showed that RHPS4 sensitivity was unchanged in U251MG and BLM −/− (IC50 was 0.56 μM in both cell lines). f Short-term cell proliferation in untreated cells, U251MG and BLM −/− , and in RHPS4-treated cells (0.5 μM) as evaluated 48 and 96 h after the first treatment. g Long-term cell proliferation in U251MG and BLM −/− untreated and RHPS4-treated cells (0.5 μM). Scale bars represent 5 μm. * p < 0.05, ** p < 0.01 (two-way ANOVA; n = 3). Error bars denote the standard deviation of the mean.
    Mouse Monoclonal Anti Trf2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 166 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti-trf2/TRF2+Antibody/pmc12830668-280-42-48
    Average 93 stars, based on 166 article reviews
    mouse monoclonal anti trf2 - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "BLM and FANCJ role in the response to G-quadruplex-dependent telomeric replicative stress"

    Article Title: BLM and FANCJ role in the response to G-quadruplex-dependent telomeric replicative stress

    Journal: Communications Biology

    doi: 10.1038/s42003-025-09367-z

    a The diagram shows the workflow on a timeline: on the day after cell seeding, cells were treated with RHPS4 (0.2 and/or 0.5 μM). At 48 h after treatment, cells were again treated with RHPS4 (0.2 and/or 0.5 μM) or harvested and counted. At 72 h after the first treatment, the cell viability was checked, and finally at 96 h after the first treatment, the cells were harvested and processed. b Representative images showing U251MG cells stained by immunofluorescence using anti-BLM (red signals), and anti-TRF1 or anti-TRF2 (green signals) antibodies. Merged images allow visualization of colocalizing dots (yellow signals). Yellow arrows indicate BLM and TRF1-TRF2 colocalizations. c Quantification of the colocalizations between BLM and TRF1 or TRF2 proteins in U251MG cell line upon RHPS4 treatment (0.2 and 0.5 μM). d , e Sensitivity of U251MG and BLM −/− cell lines to RHPS4 concentrations ranging from 0.01 to 2 μM (0.01; 0.125; 0.25; 0.5; 1; 2 μM), evaluated 96 h after the first treatment. Mitomycin C (MMC) was used as a positive control at concentrations of 0.1; 0.5; 1; 2; 5 μg/ml. The Sulforhodamine B (SRB) cytotoxicity assay showed that RHPS4 sensitivity was unchanged in U251MG and BLM −/− (IC50 was 0.56 μM in both cell lines). f Short-term cell proliferation in untreated cells, U251MG and BLM −/− , and in RHPS4-treated cells (0.5 μM) as evaluated 48 and 96 h after the first treatment. g Long-term cell proliferation in U251MG and BLM −/− untreated and RHPS4-treated cells (0.5 μM). Scale bars represent 5 μm. * p < 0.05, ** p < 0.01 (two-way ANOVA; n = 3). Error bars denote the standard deviation of the mean.
    Figure Legend Snippet: a The diagram shows the workflow on a timeline: on the day after cell seeding, cells were treated with RHPS4 (0.2 and/or 0.5 μM). At 48 h after treatment, cells were again treated with RHPS4 (0.2 and/or 0.5 μM) or harvested and counted. At 72 h after the first treatment, the cell viability was checked, and finally at 96 h after the first treatment, the cells were harvested and processed. b Representative images showing U251MG cells stained by immunofluorescence using anti-BLM (red signals), and anti-TRF1 or anti-TRF2 (green signals) antibodies. Merged images allow visualization of colocalizing dots (yellow signals). Yellow arrows indicate BLM and TRF1-TRF2 colocalizations. c Quantification of the colocalizations between BLM and TRF1 or TRF2 proteins in U251MG cell line upon RHPS4 treatment (0.2 and 0.5 μM). d , e Sensitivity of U251MG and BLM −/− cell lines to RHPS4 concentrations ranging from 0.01 to 2 μM (0.01; 0.125; 0.25; 0.5; 1; 2 μM), evaluated 96 h after the first treatment. Mitomycin C (MMC) was used as a positive control at concentrations of 0.1; 0.5; 1; 2; 5 μg/ml. The Sulforhodamine B (SRB) cytotoxicity assay showed that RHPS4 sensitivity was unchanged in U251MG and BLM −/− (IC50 was 0.56 μM in both cell lines). f Short-term cell proliferation in untreated cells, U251MG and BLM −/− , and in RHPS4-treated cells (0.5 μM) as evaluated 48 and 96 h after the first treatment. g Long-term cell proliferation in U251MG and BLM −/− untreated and RHPS4-treated cells (0.5 μM). Scale bars represent 5 μm. * p < 0.05, ** p < 0.01 (two-way ANOVA; n = 3). Error bars denote the standard deviation of the mean.

    Techniques Used: Staining, Immunofluorescence, Positive Control, Cytotoxicity Assay, Standard Deviation

    Related Articles

    Incubation:

    Article Title: BLM and FANCJ role in the response to G-quadruplex-dependent telomeric replicative stress
    Article Snippet: .. The slides were then incubated in blocking buffer (1% BSA dissolved in 1X PBS [w/v]) and then incubated overnight (ON) at 4 °C with the primary antibodies (rabbit polyclonal anti-BLM (#A300-110A, Bethyl) (1:100); mouse monoclonal anti-TRF1 (4E4 clone, GTX70304, GeneTex) (1:20) or mouse monoclonal anti-TRF2 (9F10 clone, sc-47693, Santa Cruz Biotechnology) (1:100)). .. The day after, the slides were washed three times in 1% BSA and then incubated with secondary antibodies (Alexa Fluor 488 goat anti-mouse (Invitrogen) and Alexa Fluor 546 goat anti-rabbit (Invitrogen)) diluted in blocking buffer.

    Blocking Assay:

    Article Title: BLM and FANCJ role in the response to G-quadruplex-dependent telomeric replicative stress
    Article Snippet: .. The slides were then incubated in blocking buffer (1% BSA dissolved in 1X PBS [w/v]) and then incubated overnight (ON) at 4 °C with the primary antibodies (rabbit polyclonal anti-BLM (#A300-110A, Bethyl) (1:100); mouse monoclonal anti-TRF1 (4E4 clone, GTX70304, GeneTex) (1:20) or mouse monoclonal anti-TRF2 (9F10 clone, sc-47693, Santa Cruz Biotechnology) (1:100)). .. The day after, the slides were washed three times in 1% BSA and then incubated with secondary antibodies (Alexa Fluor 488 goat anti-mouse (Invitrogen) and Alexa Fluor 546 goat anti-rabbit (Invitrogen)) diluted in blocking buffer.

    Western Blot:

    Article Title: Doxorubicin-Induced Cardiac Senescence Is Alleviated Following Treatment with Combined Polyphenols and Micronutrients through Enhancement in Mitophagy
    Article Snippet: Densitometric analysis of the bands, relative to housekeeping proteins β-Actin or GAPDH, was determined by ImageJ Software v1.51 (NIH, Bethesda, MD, USA). .. The following primary antibodies were used for Western Blot analysis: mouse monoclonal anti-p21 (sc-6264; Santa Cruz Biotechnology, Inc., Dallas, TX, USA); mouse monoclonal anti-p16 (sc-1661; Santa Cruz Biotechnology Inc., Dallas, TX, USA); rabbit polyclonal anti-phospho-p53 (Ser15) (#9284; Cell Signaling Technology Inc., Danvers, MA, USA); rabbit polyclonal anti-total p53 (sc-6243; Santa Cruz Biotechnology, Inc., Dallas, TX, USA); rabbit monoclonal anti-phospho (Ser795) Rb (#9301; Cell Signaling Technology Inc., Danvers, MA, USA); mouse monoclonal anti-Rb (sc-102; Santa Cruz Biotechnology Inc., Dallas, TX, USA); mouse monoclonal anti-TRF1 (NB110-68281, Novus Biologicals, Centennial, CO, USA); mouse monoclonal anti-TRF2 (sc-271710; Santa Cruz Biotechnology Inc., Dallas, TX, USA); mouse monoclonal anti-cyclin D1 (sc-450; Santa Cruz Biotechnology Inc., Dallas, TX, USA); rabbit polyclonal anti-PARP1 (sc-7150; Santa Cruz Biotechnology Inc., Dallas, TX, USA); rabbit monoclonal anti-SIRT1 (#9475; Cell Signaling Technology Inc., Danvers, MA, USA); rabbit monoclonal anti-SIRT2 (#12650; Cell Signaling Technology Inc., Danvers, MA, USA); rabbit monoclonal anti-SIRT3 (#5490; Cell Signaling Technology Inc., Danvers, MA, USA); rabbit polyclonal anti-SIRT4 (S0948; Sigma-Aldrich_MERCK, St. Louis, MO, USA); mouse monoclonal anti-SIRT5 (sc-271635; Santa Cruz Biotechnology Inc., Dallas, TX, USA); rabbit monoclonal anti-SIRT6 (#12486; Cell Signaling Technology Inc., Danvers, MA, USA); mouse monoclonal anti-SIRT7 (sc-365344; Santa Cruz Biotechnology Inc., Dallas, TX, USA); rabbit monoclonal anti-acetyl (K122) SOD2/MnSOD (ab214675; Abcam, Cambridge, UK); rabbit polyclonal anti SOD2/MnSOD (ab13533; Abcam, Cambridge, UK); rabbit polyclonal anti LC3B (NB600-1384, Novus Biologicals, Centennial, CO, USA); mouse monoclonal anti-Parkin (sc-32282; Santa Cruz Biotechnology Inc., Dallas, TX, USA); mouse monoclonal anti-BNIP3 (sc-56167; Santa Cruz Biotechnology Inc., Dallas, TX, USA); mouse monoclonal anti β-Actin (A5316, Sigma-Aldrich–MERCK, St. Louis, MO, USA); mouse monoclonal anti-GAPDH (sc-137179; Santa Cruz Biotechnology Inc., Dallas, TX, USA). .. In order to establish the concentration of A5 + able to promote beneficial effects without exerting toxic effects, H9C2 cells were treated with different concentrations of A5 + (1, 5, 10, 25, 50, 100, 200, and 500 μM) for 24 h. CellTiter 96 ® AQueous Solution Cell Proliferation Assay (Promega Corporation, Madison, WI, USA) was used as a metabolic assay for cell viability.

    Article Title: Doxorubicin-Induced Cardiac Senescence Is Alleviated Following Treatment with Combined Polyphenols and Micronutrients through Enhancement in Mitophagy.
    Article Snippet: Densitometric analysis of the bands, relative to housekeeping proteins β-Actin or GAPDH, was determined by ImageJ Software v1.51 (NIH, Bethesda, MD, USA). .. The following primary antibodies were used for Western Blot analysis: mouse monoclonal anti-p21 (sc-6264; Santa Cruz Biotechnology, Inc., Dallas, TX, USA); mouse monoclonal anti-p16 (sc-1661; Santa Cruz Biotechnology Inc., Dallas, TX, USA); rabbit polyclonal anti-phospho-p53 (Ser15) (#9284; Cell Signaling Technology Inc., Danvers, MA, USA); rabbit polyclonal anti-total p53 (sc-6243; Santa Cruz Biotechnology, Inc., Dallas, TX, USA); rabbit monoclonal anti-phospho (Ser795) Rb (#9301; Cell Signaling Technology Inc., Danvers, MA, USA); mouse monoclonal anti-Rb (sc-102; Santa Cruz Biotechnology Inc., Dallas, TX, Cells 2023, 12, 2605 4 of 23 USA); mouse monoclonal anti-TRF1 (NB110-68281, Novus Biologicals, Centennial, CO, USA); mouse monoclonal anti-TRF2 (sc-271710; Santa Cruz Biotechnology Inc., Dallas, TX, USA); mouse monoclonal anti-cyclin D1 (sc-450; Santa Cruz Biotechnology Inc., Dallas, TX, USA); rabbit polyclonal anti-PARP1 (sc-7150; Santa Cruz Biotechnology Inc., Dallas, TX, USA); rabbit monoclonal anti-SIRT1 (#9475; Cell Signaling Technology Inc., Danvers, MA, USA); rabbit monoclonal anti-SIRT2 (#12650; Cell Signaling Technology Inc., Danvers, MA, USA); rabbit monoclonal anti-SIRT3 (#5490; Cell Signaling Technology Inc., Danvers, MA, USA); rabbit polyclonal anti-SIRT4 (S0948; Sigma-Aldrich_MERCK, St. Louis, MO, USA); mouse monoclonal anti-SIRT5 (sc-271635; Santa Cruz Biotechnology Inc., Dallas, TX, USA); rabbit monoclonal anti-SIRT6 (#12486; Cell Signaling Technology Inc., Danvers, MA, USA); mouse monoclonal anti-SIRT7 (sc-365344; Santa Cruz Biotechnology Inc., Dallas, TX, USA); rabbit monoclonal anti-acetyl (K122) SOD2/MnSOD (ab214675; Abcam, Cambridge, UK); rabbit polyclonal anti SOD2/MnSOD (ab13533; Abcam, Cambridge, UK); rabbit polyclonal anti LC3B (NB600-1384, Novus Biologicals, Centennial, CO, USA); mouse monoclonal anti-Parkin (sc-32282; Santa Cruz Biotechnology Inc., Dallas, TX, USA); mouse monoclonal anti-BNIP3 (sc-56167; Santa Cruz Biotechnology Inc., Dallas, TX, USA); mouse monoclonal anti β-Actin (A5316, Sigma-Aldrich–MERCK, St. Louis, MO, USA); mouse monoclonal anti-GAPDH (sc-137179; Santa Cruz Biotechnology Inc., Dallas, TX, USA). .. In order to establish the concentration of A5+ able to promote beneficial effects without exerting toxic effects, H9C2 cells were treated with different concentrations of A5+ (1, 5, 10, 25, 50, 100, 200, and 500 μM) for 24 h. CellTiter 96® AQueous Solution Cell Proliferation Assay (Promega Corporation, Madison, WI, USA) was used as a metabolic assay for cell viability.

    SDS Page:

    Article Title: Association of a Platinum Complex to a G-Quadruplex Ligand Enhances Telomere Disruption.
    Article Snippet: Chemical Research in Toxicology is published by the American Chemical Society.. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society.. Copyright © American Chemical Society.

    Article Title: Pt-ttpy, a G-quadruplex binding platinum complex, induces telomere dysfunction and G-rich regions DNA damage.
    Article Snippet: Western blots were performed following Bio-Rad protocol. .. Briefly, 20 μg proteins were electrophoresed in SDS-PAGE (SDSPolyacrylamide 10%) under denaturing conditions, then transferred to a PVDFmembrane (Polyvinylidin Difluoride) (Amersham HybondTM P+, GE Healthcare) or nitrocellulose, which were hybridized with mouse monoclonal anti-TRF2 antibody (4A794, Upstate), the Anti-TRF2 Thr-188P polyclonal antibody, and antiactin HRP (SC1616-HRP, Santa-Cruz). .. TRF2 was revealed by the secondary antibody goat anti-mouse IgG-HRP (ab6789, abcam) using the ECL Western Blotting detection reagent.

    Membrane:

    Article Title: Association of a Platinum Complex to a G-Quadruplex Ligand Enhances Telomere Disruption.
    Article Snippet: Chemical Research in Toxicology is published by the American Chemical Society.. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society.. Copyright © American Chemical Society.



    Similar Products

    93
    Santa Cruz Biotechnology mouse monoclonal anti trf2
    a The diagram shows the workflow on a timeline: on the day after cell seeding, cells were treated with RHPS4 (0.2 and/or 0.5 μM). At 48 h after treatment, cells were again treated with RHPS4 (0.2 and/or 0.5 μM) or harvested and counted. At 72 h after the first treatment, the cell viability was checked, and finally at 96 h after the first treatment, the cells were harvested and processed. b Representative images showing U251MG cells stained by immunofluorescence using anti-BLM (red signals), and anti-TRF1 <t>or</t> <t>anti-TRF2</t> (green signals) antibodies. Merged images allow visualization of colocalizing dots (yellow signals). Yellow arrows indicate BLM and TRF1-TRF2 colocalizations. c Quantification of the colocalizations between BLM and TRF1 or TRF2 proteins in U251MG cell line upon RHPS4 treatment (0.2 and 0.5 μM). d , e Sensitivity of U251MG and BLM −/− cell lines to RHPS4 concentrations ranging from 0.01 to 2 μM (0.01; 0.125; 0.25; 0.5; 1; 2 μM), evaluated 96 h after the first treatment. Mitomycin C (MMC) was used as a positive control at concentrations of 0.1; 0.5; 1; 2; 5 μg/ml. The Sulforhodamine B (SRB) cytotoxicity assay showed that RHPS4 sensitivity was unchanged in U251MG and BLM −/− (IC50 was 0.56 μM in both cell lines). f Short-term cell proliferation in untreated cells, U251MG and BLM −/− , and in RHPS4-treated cells (0.5 μM) as evaluated 48 and 96 h after the first treatment. g Long-term cell proliferation in U251MG and BLM −/− untreated and RHPS4-treated cells (0.5 μM). Scale bars represent 5 μm. * p < 0.05, ** p < 0.01 (two-way ANOVA; n = 3). Error bars denote the standard deviation of the mean.
    Mouse Monoclonal Anti Trf2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti-trf2/TRF2+Antibody/pmc12830668-280-42-48
    Average 93 stars, based on 1 article reviews
    mouse monoclonal anti trf2 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Millipore mouse monoclonal anti-trf2 clone 4a794

    Mouse Monoclonal Anti Trf2 Clone 4a794, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti-trf2/anti+trf2/pmc11530851-12-0-6
    Average 90 stars, based on 1 article reviews
    mouse monoclonal anti-trf2 clone 4a794 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    Novus Biologicals anti trf2 mouse monoclonal

    Anti Trf2 Mouse Monoclonal, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti-trf2/TRF-2+Antibody+(4A794%2E15)+-+Azide+Free/pm36426578-439-7-10
    Average 93 stars, based on 1 article reviews
    anti trf2 mouse monoclonal - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Millipore mouse monoclonal antibody (mab) anti-terf2/trf2 4a794

    Mouse Monoclonal Antibody (Mab) Anti Terf2/Trf2 4a794, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti-trf2/anti+trf2/pm36310382-216-13-19
    Average 90 stars, based on 1 article reviews
    mouse monoclonal antibody (mab) anti-terf2/trf2 4a794 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Millipore mouse monoclonal anti-trf2 05-521

    Mouse Monoclonal Anti Trf2 05 521, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti-trf2/anti+trf2/pmc09522348__pnas__2208669119__sapp-50-7-10
    Average 90 stars, based on 1 article reviews
    mouse monoclonal anti-trf2 05-521 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Millipore anti-trf2, mouse monoclonal

    Anti Trf2, Mouse Monoclonal, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti-trf2/anti+trf2/pm35385755-188-7-17
    Average 90 stars, based on 1 article reviews
    anti-trf2, mouse monoclonal - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    a The diagram shows the workflow on a timeline: on the day after cell seeding, cells were treated with RHPS4 (0.2 and/or 0.5 μM). At 48 h after treatment, cells were again treated with RHPS4 (0.2 and/or 0.5 μM) or harvested and counted. At 72 h after the first treatment, the cell viability was checked, and finally at 96 h after the first treatment, the cells were harvested and processed. b Representative images showing U251MG cells stained by immunofluorescence using anti-BLM (red signals), and anti-TRF1 or anti-TRF2 (green signals) antibodies. Merged images allow visualization of colocalizing dots (yellow signals). Yellow arrows indicate BLM and TRF1-TRF2 colocalizations. c Quantification of the colocalizations between BLM and TRF1 or TRF2 proteins in U251MG cell line upon RHPS4 treatment (0.2 and 0.5 μM). d , e Sensitivity of U251MG and BLM −/− cell lines to RHPS4 concentrations ranging from 0.01 to 2 μM (0.01; 0.125; 0.25; 0.5; 1; 2 μM), evaluated 96 h after the first treatment. Mitomycin C (MMC) was used as a positive control at concentrations of 0.1; 0.5; 1; 2; 5 μg/ml. The Sulforhodamine B (SRB) cytotoxicity assay showed that RHPS4 sensitivity was unchanged in U251MG and BLM −/− (IC50 was 0.56 μM in both cell lines). f Short-term cell proliferation in untreated cells, U251MG and BLM −/− , and in RHPS4-treated cells (0.5 μM) as evaluated 48 and 96 h after the first treatment. g Long-term cell proliferation in U251MG and BLM −/− untreated and RHPS4-treated cells (0.5 μM). Scale bars represent 5 μm. * p < 0.05, ** p < 0.01 (two-way ANOVA; n = 3). Error bars denote the standard deviation of the mean.

    Journal: Communications Biology

    Article Title: BLM and FANCJ role in the response to G-quadruplex-dependent telomeric replicative stress

    doi: 10.1038/s42003-025-09367-z

    Figure Lengend Snippet: a The diagram shows the workflow on a timeline: on the day after cell seeding, cells were treated with RHPS4 (0.2 and/or 0.5 μM). At 48 h after treatment, cells were again treated with RHPS4 (0.2 and/or 0.5 μM) or harvested and counted. At 72 h after the first treatment, the cell viability was checked, and finally at 96 h after the first treatment, the cells were harvested and processed. b Representative images showing U251MG cells stained by immunofluorescence using anti-BLM (red signals), and anti-TRF1 or anti-TRF2 (green signals) antibodies. Merged images allow visualization of colocalizing dots (yellow signals). Yellow arrows indicate BLM and TRF1-TRF2 colocalizations. c Quantification of the colocalizations between BLM and TRF1 or TRF2 proteins in U251MG cell line upon RHPS4 treatment (0.2 and 0.5 μM). d , e Sensitivity of U251MG and BLM −/− cell lines to RHPS4 concentrations ranging from 0.01 to 2 μM (0.01; 0.125; 0.25; 0.5; 1; 2 μM), evaluated 96 h after the first treatment. Mitomycin C (MMC) was used as a positive control at concentrations of 0.1; 0.5; 1; 2; 5 μg/ml. The Sulforhodamine B (SRB) cytotoxicity assay showed that RHPS4 sensitivity was unchanged in U251MG and BLM −/− (IC50 was 0.56 μM in both cell lines). f Short-term cell proliferation in untreated cells, U251MG and BLM −/− , and in RHPS4-treated cells (0.5 μM) as evaluated 48 and 96 h after the first treatment. g Long-term cell proliferation in U251MG and BLM −/− untreated and RHPS4-treated cells (0.5 μM). Scale bars represent 5 μm. * p < 0.05, ** p < 0.01 (two-way ANOVA; n = 3). Error bars denote the standard deviation of the mean.

    Article Snippet: The slides were then incubated in blocking buffer (1% BSA dissolved in 1X PBS [w/v]) and then incubated overnight (ON) at 4 °C with the primary antibodies (rabbit polyclonal anti-BLM (#A300-110A, Bethyl) (1:100); mouse monoclonal anti-TRF1 (4E4 clone, GTX70304, GeneTex) (1:20) or mouse monoclonal anti-TRF2 (9F10 clone, sc-47693, Santa Cruz Biotechnology) (1:100)).

    Techniques: Staining, Immunofluorescence, Positive Control, Cytotoxicity Assay, Standard Deviation

    Journal: iScience

    Article Title: Human SKI component SKIV2L regulates telomeric DNA-RNA hybrids and prevents telomere fragility

    doi: 10.1016/j.isci.2024.111096

    Figure Lengend Snippet:

    Article Snippet: Mouse monoclonal anti-TRF2 (Clone 4A794) , Millipore , Cat#05-521; RRID: AB_2303145.

    Techniques: Virus, Recombinant, Protease Inhibitor, Reverse Transcription, Blocking Assay, Mass Spectrometry, SYBR Green Assay, Flow Cytometry, Imaging, Mutagenesis, Cell Cycle Assay, shRNA, Software